期刊文献+

神经内科重症监护病房抗癫痫药引发药品不良反应报告分析 被引量:2

Analysis of Adverse Drug Reactions Induced by Anti-epileptic Medicines in Intensive Care Unit of Neurology
原文传递
导出
摘要 目的:探讨住院患者使用抗癫痫药出现的不良反应,为神经内科危重患者合理使用抗癫痫药提供参考。方法:采用回顾性调查方法,对2006年5月~2007年11月我院神经内科重症监护病房继发性癫痫患者抗癫痫药引发的不良反应报告进行分析。结果:神经内科重症监护病房抗癫痫药引发的不良反应有24例,占总数的47.06%(24/51)。引起不良反应的药品主要有卡马西平、丙戊酸钠、奥卡西平和苯巴比妥;不良反应的表现有皮疹、白细胞减少、肝功能异常及低钠血症等。经及时救治,全部治愈。结论:临床医师在选择药品时应充分考虑药品的风险/效益比,尽量选择疗效明显、副作用小的药品,以减少不良反应对患者的损害。 OBJECTIVE: To analyze the adverse drug reactions(ADR) caused by anti - epileptic medicines used for pa- tients in the Neurological Intensive Care Unit (ICU) for reference of rational use of anti- epileptic medicines. METHODS: The ADR induced by anti - epileptic drugs between May 2006 and Nov. 2007 in neurological ICU patients with secondary epilepsy were analyzed retrospectively. RESULTS: A total of 24 ADR cases (24/50, 47.06%) induced by anti- epileptic drugs were reported from Neurological Intensive Care Unit(ICU) . The ADR were mainly induced by carbamazepine, valproate sodium, oxcarbazepine and phenobarbital, and the ADR mainly appeared as skin rash, hypolekocytosis, hepatic dysfunction and hyponatremia etc, but all cured after prompt treatment. CONCLUSION: The risk/efficiency ratio should be considered in clinical use of anti - epileptic drugs, and those drugs showing remarkable efficacy and few adverse reactions should be used preferably to reduce the damage to patients caused by ADR.
出处 《中国药房》 CAS CSCD 北大核心 2009年第17期1344-1346,共3页 China Pharmacy
关键词 神经内科 重症监护病房 抗癫痫药 药品不良反应 Dept. of neurology Intensive care unit Anti- epileptic medicine Adverse drug reactions
  • 相关文献

参考文献4

二级参考文献45

  • 1李清,周宏灏.个体化用药——医药治疗的革命[J].医学与哲学,2005,26(6):52-54. 被引量:7
  • 2Johannessen SI, Battino D, Berry DJ, et al. Therapeutic drug monitoring of the newer antiepileptic drugs[J]. Ther Drug Monit, 2003, 25(3):347-363.
  • 3Hirose S, Okada M, Kaneko S, et al. Are some idiopathic epilepsies disorders of ion channels? : A working hypothesis[J]. Epilepsy Res, 2000, 41 (3): 191-204.
  • 4Steinlein OK. Genes and mutations in human idiopathic epilepsy[J]. Brain Dev, 2004, 26(4):213-218.
  • 5Lenzen KP, Hells A, Lorenz S, et al. Supportive evidence for an allelic association of the human KCNJ10 potassium channel gene with idiopathic generalized epilepsy[J]. Epilepsy Res, 2005, 63(2-3) :13-118.
  • 6Kath Senior. Gene variants affect response to antiepileptic drugs [J]. Lancet Neurol, May; 2005, 4(5):276-227.
  • 7Tate SK, Depondt C, Sisodiya SM et al. Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. [J] PNAS, 2005, 102 (15): 5507-5512.
  • 8Remy S, Gabriel S, Urban BW, et al. A novel mechanism underlying drug resistance in chronic epilepsy. [J]Ann Neurol, 2003, 53(4):469-479.
  • 9Anderson GD. Pharmacogenetics and enzyme induc tion/inhibition properties of antiepileptic drugs [J]. Neurology, 2004, 63(Suppl 4): S3-S8.
  • 10Komatsu T, Yamazaki H, Asahi S, et al. Formation of a dihydroxy netabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9,2C19, and 3A4. [J]. Drug Metab Dispos, 2000, 28 (11):1361-1368.

共引文献8

同被引文献10

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部